Smaller Wichita school bond vote not on horizon, district says. ‘We have no plans'
Wichita school district officials say they don't have plans now to come back to voters to ask for a smaller bond issue vote.
Voters narrowly rejected a $450 million bond issue earlier this year.
'We have no plans,' the district's Chief Financial Officer Addi Lowell said Thursday at the first meeting of a new citizen financial oversight committee.
That committee could eventually come back with a recommendation for another public vote on a bond proposal, though.
Right after the February election, officials with the district and the Vote Yes campaign had signaled that a smaller bond vote could be a possibility.
The newly formed committee, mostly composed of community members with financial backgrounds and some USD 259 parents and students, is an advisory group that can make recommendations to the district's school board.
It's tasked with finding short-term financial solutions for the district, which is likely to face significant financial challenges as deferred maintenance costs on school buildings continue to increase. The district had hoped to replace a bond issue that falls off the tax rolls in 2029 with a new one to address some of its building issues.
'Today we're focusing on the short-term options,' Lowell said. 'I've got to focus on the budget for next fiscal year and we can engage in future meetings about our long term options, certainly.'
Those short-term options could include finding outside funding, reducing the district's operating budget, or closing schools, among others.
The committee did not signal which direction it planned to go in its first meeting, but it could make some recommendations at its next meeting in May.
'I could summarize school finance in, there's never enough resources to do all the things we want to do for our kids and keep up with our infrastructure needs,' Lowell said.
USD 259 wouldn't be the first district in the state of Kansas to come back and ask for a smaller bond issue in recent memory.
Voters in the Kansas City, Kansas school district rejected a $480 million bond issue in early 2024. The district then downsized its plans to a $180 million bond issue, which passed several months later.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
2 days ago
- Boston Globe
Will Trump's policies kill Massachusetts' life sciences leadership?
Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us
Yahoo
3 days ago
- Yahoo
Prominent lawyers join press freedom fight to thwart Paramount settlement with Trump
With new legal muscle, the nonprofit Freedom of the Press Foundation is upping pressure on Paramount Global to abandon efforts to settle President Trump's $20-billion lawsuit targeting CBS and "60 Minutes." Respected Washington litigator Abbe David Lowell this week joined the team representing the New York advocacy group, which has vowed to sue Paramount should it settle with Trump. The group owns Paramount shares. Lowell, who has represented Hunter Biden, Ivanka Trump and Jared Kushner, is working on the case with attorney Norm Eisen, a Trump critic who helped House Democrats with strategy during Trump's first impeachment hearings in 2019. Eisen is a former ambassador to the Czech Republic who served as White House ethics advisor under President Obama. Late Thursday, the two attorneys sent a strongly worded letter to Paramount's chairwoman and controlling shareholder Shari Redstone and other board members arguing that a Trump settlement would cause "catastrophic" harm to the embattled media company. 1st Amendment experts have labeled Trump's lawsuit frivolous. But Paramount leaders are desperate to end the Trump drama and some believe a truce could clear a path for the Federal Communications Commission to approve the company's $8-billion sale to David Ellison's Skydance Media. Paramount needs the FCC to authorize the transfer of the CBS station licenses to the Ellison family. The prospect of a Trump settlement has carved deep divisions within Paramount, which includes CBS News and "60 Minutes." 'Trading away the credibility of CBS's news division to curry favor with the Trump Administration is an improper and reckless act that will irreparably damage the company's brand and destroy shareholder value," Lowell said in a statement late Thursday. "The board is legally and morally obligated to protect the company, not auction off its integrity for regulatory approval," Lowell said. Read more: Why Paramount's efforts to settle Trump's lawsuit have drawn mounting political heat The FCC review of Skydance's proposed takeover of Paramount has become a slog. Skydance and Paramount face an October deadline to finalize the sale or the deal could collapse. Paramount, in a statement, said that it is treating the FCC review and the Trump lawsuit as separate matters. "We will abide by the legal process to defend our case,' a corporate spokesman said. Paramount's lawyers entered mediation with the president's legal team in late April, but no resolution has been reached. Paramount offered $15 million to Trump to end his suit, according to the Wall Street Journal, but the president rejected the overture and asked for more. On Thursday, Redstone disclosed that she has been diagnosed with thyroid cancer and is receiving treatment. Last month, doctors removed her thyroid but cancer cells had spread to her vocal chords. Read more: Paramount chair Shari Redstone has been diagnosed with thyroid cancer In their seven-page letter, Lowell and Eisen told Paramount's leaders that, should they approve a Trump settlement to gain traction at the FCC, they would be violating their fiduciary duty to shareholders and potentially breaking federal anti-bribery statutes. "We believe [a settlement] could violate laws prohibiting bribery of public officials, thereby causing severe and last damage to Paramount and its shareholders," Lowell and Eisen wrote. "To be as clear as possible, you control what happens next," they said. The admonition follows a similar warning from three U.S. senators — Elizabeth Warren (D-Mass.), Bernie Sanders (I-Vt) and Ron Wyden (D-Ore.) In a May 19 letter, the senators wrote that paying money to Trump to help win clearance for the Paramount sale could constitute a bribe. 'It is illegal to corruptly give anything of value to public officials to influence an official act,' the three senators wrote in their letter. Read more: '60 Minutes,' the Associated Press, an Iowa newspaper: Trump's attacks on the media reach new heights In addition, two California Democrats have proposed a state Senate hearing to examine problems with a possible Trump settlement. The senators invited two former CBS News executives — who both left, in large part, because of the controversy — to testify before a yet-unscheduled joint committee hearing in Sacramento. The California lawmakers, in their letter, said a Trump settlement could also violate California's Unfair Competition Law because it could disrupt the playing field for news organizations. Earlier this week, Paramount asked shareholders to increase the size of its board to seven members at the company's annual investor meeting next month. The Freedom of the Press Foundation was created in 2012 to protect and defend public interest journalism. This spring, Lowell left his former major law firm, Winston & Strawn, where he had been a partner for years. He formed his own boutique firm, Lowell & Assoc., with a focus on "public interest representation in matters that defend the integrity of the legal system and protect individuals and institutions from government overreach," according to its website. Read more: Trump, '60 Minutes' and corruption allegations put Paramount on edge with sale less certain Lowell's firm also includes lawyer Brenna Frey, who made a high-profile exit from another prominent law firm, Skadden Arps, after it cut a deal with Trump to avoid becoming a target. That law firm agreed to provide $100 million in free legal services. Last month, Frey appeared on CBS' "60 Minutes" to air her decision to resign from Skadden Arps. 'I was able to tell my story on CBS's '60 Minutes' because of the independence of a courageous news division, which is what's at risk now," Frey said in a statement. Sign up for our Wide Shot newsletter to get the latest entertainment business news, analysis and insights. This story originally appeared in Los Angeles Times.
Los Angeles Times
3 days ago
- Los Angeles Times
Prominent lawyers join press freedom fight to thwart Paramount settlement with Trump
With new legal muscle, the nonprofit Freedom of the Press Foundation is upping pressure on Paramount Global to abandon efforts to settle President Trump's $20-billion lawsuit targeting CBS and '60 Minutes.' Respected Washington litigator Abbe David Lowell this week joined the team representing the New York advocacy group, which has vowed to sue Paramount should it settle with Trump. The group owns Paramount shares. Lowell, who has represented Hunter Biden, Ivanka Trump and Jared Kushner, is working on the case with attorney Norm Eisen, a Trump critic who helped House Democrats with strategy during Trump's first impeachment hearings in 2019. Eisen is a former ambassador to the Czech Republic who served as White House ethics advisor under President Obama. Late Thursday, the two attorneys sent a strongly worded letter to Paramount's chairwoman and controlling shareholder Shari Redstone and other board members arguing that a Trump settlement would cause 'catastrophic' harm to the embattled media company. 1st Amendment experts have labeled Trump's lawsuit frivolous. But Paramount leaders are desperate to end the Trump drama and some believe a truce could clear a path for the Federal Communications Commission to approve the company's $8-billion sale to David Ellison's Skydance Media. Paramount needs the FCC to authorize the transfer of the CBS station licenses to the Ellison family. The prospect of a Trump settlement has carved deep divisions within Paramount, which includes CBS News and '60 Minutes.' 'Trading away the credibility of CBS's news division to curry favor with the Trump Administration is an improper and reckless act that will irreparably damage the company's brand and destroy shareholder value,' Lowell said in a statement late Thursday. 'The board is legally and morally obligated to protect the company, not auction off its integrity for regulatory approval,' Lowell said. The FCC review of Skydance's proposed takeover of Paramount has become a slog. Skydance and Paramount face an October deadline to finalize the sale or the deal could collapse. Paramount, in a statement, said that it is treating the FCC review and the Trump lawsuit as separate matters. 'We will abide by the legal process to defend our case,' a corporate spokesman said. Paramount's lawyers entered mediation with the president's legal team in late April, but no resolution has been reached. Paramount offered $15 million to Trump to end his suit, according to the Wall Street Journal, but the president rejected the overture and asked for more. On Thursday, Redstone disclosed that she has been diagnosed with thyroid cancer and is receiving treatment. Last month, doctors removed her thyroid but cancer cells had spread to her vocal chords. In their seven-page letter, Lowell and Eisen told Paramount's leaders that, should they approve a Trump settlement to gain traction at the FCC, they would be violating their fiduciary duty to shareholders and potentially breaking federal anti-bribery statutes. 'We believe [a settlement] could violate laws prohibiting bribery of public officials, thereby causing severe and last damage to Paramount and its shareholders,' Lowell and Eisen wrote. 'To be as clear as possible, you control what happens next,' they said. The admonition follows a similar warning from three U.S. senators — Elizabeth Warren (D-Mass.), Bernie Sanders (I-Vt) and Ron Wyden (D-Ore.) In a May 19 letter, the senators wrote that paying money to Trump to help win clearance for the Paramount sale could constitute a bribe. 'It is illegal to corruptly give anything of value to public officials to influence an official act,' the three senators wrote in their letter. In addition, two California Democrats have proposed a state Senate hearing to examine problems with a possible Trump settlement. The senators invited two former CBS News executives — who both left, in large part, because of the controversy — to testify before a yet-unscheduled joint committee hearing in Sacramento. The California lawmakers, in their letter, said a Trump settlement could also violate California's Unfair Competition Law because it could disrupt the playing field for news organizations. Earlier this week, Paramount asked shareholders to increase the size of its board to seven members at the company's annual investor meeting next month. The Freedom of the Press Foundation was created in 2012 to protect and defend public interest journalism. This spring, Lowell left his former major law firm, Winston & Strawn, where he had been a partner for years. He formed his own boutique firm, Lowell & Assoc., with a focus on 'public interest representation in matters that defend the integrity of the legal system and protect individuals and institutions from government overreach,' according to its website. Lowell's firm also includes lawyer Brenna Frey, who made a high-profile exit from another prominent law firm, Skadden Arps, after it cut a deal with Trump to avoid becoming a target. That law firm agreed to provide $100 million in free legal services. Last month, Frey appeared on CBS' '60 Minutes' to air her decision to resign from Skadden Arps. 'I was able to tell my story on CBS's '60 Minutes' because of the independence of a courageous news division, which is what's at risk now,' Frey said in a statement.
